← Back to Search

Behavioral Intervention

Individualized imagery for Psychosis

N/A

Waitlist Available

Led By Alia Warner

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Primary diagnoses of schizophrenia spectrum disorder or mood disorder with psychotic features, as determined by the treatment team or record review

Reported sleep dysfunction which will be determined by a subthreshold or more severe score ≥ 8 on the Insomnia Severity Index (ISI), and/or report experiencing nightmares at least once a week.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post-intervention(upto 80 days after baseline )

Awards & highlights

Study Summary

This trial aims to test if using a small EEG device and audio technology can help improve sleep and symptoms in hospitalized patients with psychosis.

Who is the study for?

This trial is for inpatients with psychosis who often have trouble sleeping, experience severe mental illness symptoms, or have suicidal thoughts. Participants should be willing to use EEG and audio technology for sleep interventions.Check my eligibility

What is being tested?

The study tests if using compact EEG devices with personalized audio can improve sleep and reduce symptoms of psychosis. Patients will either receive individualized imagery scripts (intervention) or no such intervention (control).See study design

What are the potential side effects?

Since this trial involves non-invasive technology like EEG and audio scripts, side effects are minimal but may include discomfort from wearing the EEG device or emotional responses to the imagery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with schizophrenia or a mood disorder with psychosis.

Select...

I often have trouble sleeping or experience nightmares weekly.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to end of study (upto 80 days after baseline )

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to end of study (upto 80 days after baseline )

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to end of study (upto 80 days after baseline ) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility as assessed by a self-report satisfaction survey, Was It Worth It questionnaire

Feasibility as assessed by coding percentage of use per night (based on duration of physiological measures collected per night divided by hours of sleep)

Feasibility as assessed by percentage of nights used for the duration of the intervention.

Secondary outcome measures

Improvements in sleep quality as assessed by the Disturbing Dream and Nightmare Severity Index (DDNSI)

Improvements in sleep quality as assessed by the Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS)

Improvements in sleep quality as assessed by the Insomnia Severity Index (ISI)

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Individualized imageryExperimental Treatment1 Intervention

Group II: ControlActive Control1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor

905 Previous Clinical Trials

321,070 Total Patients Enrolled

1 Trials studying Psychosis

500 Patients Enrolled for Psychosis

Alia WarnerPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Jessica Badawi, Ph.D.Principal InvestigatorThe University of Texas Health Science Center, Houston

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently recruiting participants for this ongoing medical study?

"According to the information available on clinicaltrials.gov, this study is not currently seeking participants. The trial was initially listed on January 2nd, 2024 and last updated on December 21st, 2023. Although enrollment for this specific trial is closed at the moment, there are presently a total of 542 other trials actively recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

Alia Warner 2024. "The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06194344.